TrialThe lancet. HIV2019

Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial.

Martin R Gaudinski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.